Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      APCER, ArisGlobal launches cloud-based software for pharmacovigilance

      APCER, ArisGlobal launches cloud-based software for pharmacovigilance

      Ruby Khatun Khatun28 Jun 2018 10:15 AM IST
      Ahmedabad: ArisGlobal, a leading provider of integrated, multi-tenant cloud-based software solutions for life sciences and APCER Life Sciences, the...
      FDA approves automated insulin delivery and monitoring system for younger pediatric patients

      FDA approves automated insulin delivery and monitoring system for younger pediatric patients

      Ruby Khatun Khatun28 Jun 2018 10:00 AM IST
      The U.S. Food and Drug Administration (FDA) expanded the approval of the MiniMed 670G hybrid closed looped system, a diabetes management device that...
      AstraZeneca, Merck eye 1 billion dollar boost from cancer drug success

      AstraZeneca, Merck eye 1 billion dollar boost from cancer drug success

      Ruby Khatun Khatun28 Jun 2018 9:45 AM IST
      LONDON: AstraZeneca’s oncology business received a boost as results of a clinical trial showed its drug Lynparza helped women with ovarian cancer live...
      Puma Biotech says Europe likely to approve breast cancer drug

      Puma Biotech says Europe likely to approve breast cancer drug

      Ruby Khatun Khatun28 Jun 2018 9:30 AM IST
      Puma Biotechnology Inc said a committee of the European Medicines Agency was likely to give a positive opinion on its breast cancer drug, five months...
      Oxytocin manufacture banned from 1st July 2018, only this one firm will manufacture it

      Oxytocin manufacture banned from 1st July 2018, only this one firm will manufacture it

      Ruby Khatun Khatun27 Jun 2018 5:23 PM IST
      KAPL to manufacture the drug for domestic use onlyThe Ministry of Health and Family Welfare has restricted the manufacture of Oxytocin formulations...
      Fortis Healthcare Q4 loss at Rs 914 crore

      Fortis Healthcare Q4 loss at Rs 914 crore

      Ruby Khatun Khatun27 Jun 2018 11:30 AM IST
      New Delhi: Beleaguered Fortis Healthcare today reported widening of its consolidated net loss to Rs 914.32 crore for the fourth quarter ended March...
      Aurobindo Pharma gets USFDA approval for Ertapenem Injection

      Aurobindo Pharma gets USFDA approval for Ertapenem Injection

      Ruby Khatun Khatun27 Jun 2018 10:30 AM IST
      Hyderabad: Aurobindo Pharma Limited said it received final approval from the US Food and Drug Administration (USFDA) to manufacture and market...
      SMT biodegradable polymer coated stent shows extra ordinary long term safety: seven-year clinical study

      SMT biodegradable polymer coated stent shows extra ordinary long term safety: seven-year clinical study

      Ruby Khatun Khatun27 Jun 2018 10:15 AM IST
      Mumbai: SMT (Sahajanand Medical Technologies Pvt. Ltd.), India’s largest manufacturer of cardiovascular medical stents, today, announced the...
      Dementia venture fund raises 350 million dollar to hunt new drugs

      Dementia venture fund raises 350 million dollar to hunt new drugs

      Ruby Khatun Khatun27 Jun 2018 9:45 AM IST
      LONDON: A venture capital fund dedicated to finding new ways to prevent and treat dementia has raised $350 million, far exceeding the initial target...
      Lillys Jardiance meets main goal of two diabetes trials

      Lilly's Jardiance meets main goal of two diabetes trials

      Ruby Khatun Khatun27 Jun 2018 9:30 AM IST
      Eli Lilly & Co said that its drug Jardiance, along with insulin therapy, met the main goal of two trials testing it in patients with type 1...
      Over Rs 460 crore support by govt for development of pharma sector

      Over Rs 460 crore support by govt for development of pharma sector

      Ruby Khatun Khatun26 Jun 2018 3:24 PM IST
      New Delhi: The government has proposed over Rs 460 crore support for the development of pharmaceuticals industry with an aim to reduce the cost of...
      FDA approves first marijuana plant-derived drug for epilepsy

      FDA approves first marijuana plant-derived drug for epilepsy

      Ruby Khatun Khatun26 Jun 2018 10:15 AM IST
      The U.S. Food and Drug Administration (FDA) approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok